US 10576107
Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases
granted A61KA61K35/50A61K38/57
Quick answer
US patent 10576107 (Methods of treating joint diseases, disorders, and conditions with tissue inhibitors of matrix metalloproteinases) held by Prime Merger Sub, LLC expires Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Prime Merger Sub, LLC
- Grant date
- Tue Mar 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/50, A61K38/57, A61K47/36, A61K9/0019